BIOX · Bioceres Crop Solutions Corp. · Metrics
$0.21
-0.02 (-9.77%)
At close · Oct 28
Return incl. dividend (before tax)
Q4 2026 earnings call transcript
Market Cap
$15.15M
Shares
63.82M
Volume · Oct 28
378.84K
Avg daily vol (3M)
306.77K
BIOX metrics
69 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$0.25
Market cap
$15.15M
Price action
20 metricsPrice change (1W)
-5.7%
Price change (30D)
-33.7%
Price change (3M)
-26.5%
Price change (6M)
-52.1%
Price change (YTD)
-81.9%
Price change (1Y)
-88.1%
Trailing year
Price change (5Y)
-98.2%
52-week high
$2.03
52-week low
$0.20
Change from 52-week high
-88.3%
Change from 52-week low
+16.9%
Annualized volatility
98.3%
Annualized volatility (3M)
79.7%
Beta
1.8
RSI (14D)
31.9
Price vs SMA 50
-34.4%
Price vs SMA 200
-51.0%
Avg volume (3M)
301,847
Relative volume
0.8
Average dollar volume
$115,566
Company
3 metricsSector
Basic Materials
Industry
Agricultural Inputs
Shares outstanding
63.82M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,943.4%
P / book
0.2
reciprocal yield 504.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
0.2
reciprocal yield 540.4%
Earnings yield
-1,581.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-09-15
Profitability
9 metricsGross margin
39.3%
Operating margin
-1.4%
Trailing 12 months
Net margin
-16.5%
Gross profit (TTM)
$115.60M
Operating profit (TTM)
−$4.24M
Net income (TTM)
−$56.37M
Trailing 12 months
Diluted EPS (TTM)
$-3.78
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-25.3%
Year over year
Net income growth YoY
-1,396.1%
Revenue (TTM)
$294.42M
Trailing 12 months
EPS growth YoY
-125,473.9%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+0.0%
Revenue CAGR (5Y)
+14.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+42.0%
Quality
14 metricsReturn on equity
-21.8%
Return on assets
-7.7%
Debt / equity
—
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
-0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.06M
Total assets
$560.36M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$81.87M
Capital expenditures (TTM)
$3.51M
R&D (TTM)
$16.60M
SG&A (TTM)
—
Stock compensation (TTM)
$3.58M
R&D / revenue
5.6%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
29
13F filer change QoQ
-4
Institutional ownership
13.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-9.1%
Holder tenure
14.6
Price vs estimated holder cost
-96.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
2.1%
Short interest
3 metricsShort interest
1.3%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
44 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—